Document is current
Any future updates will be listed below
-
Authors
Piaserico, Stefano https://orcid.org/0000-0002-1091-4733
Gisondi, Paolo
Cazzaniga, Simone
Naldi, Luigi
- License Information
-
More Information
Article History
First Online: 18 August 2020
Declarations
:
: Stefano Piaserico has been a consultant and/or speaker for Abbvie, Almirall, Celgene, Janssen, Leo-pharma, Eli Lilly, Merck Sharp & Dohme, Novartis, Pfizer, Sandoz, and UCB. Paolo Gisondi has been a consultant and/or speaker for Abbvie, Almirall, Celgene, Janssen, Leo-pharma, Eli Lilly, Novartis, Pfizer, Sandoz, and UCB. Simone Cazzaniga has nothing to declare. Luigi Naldi has been a consultant and/or speaker for Abbvie, Almirall, Celgene, Janssen, Eli Lilly, and Novartis.
: The article has no funding source.
: Not applicable.
: Not applicable (data were anonymized).
: Not applicable (data were anonymized).
: The datasets generated during the current study are available from the corresponding author on reasonable request.
: Not applicable.
: Stefano Piaserico conceived and planned the study, interpreted the data and drafted the manuscript. Paolo Gisondi conceived and planned the study, interpreted the data and critically reviewed the manuscript. Simone Cazzaniga analyzed the data and drafted the manuscript. Luigi Naldi conceived and planned the study, interpreted the data and critically reviewed the manuscript.
Free to read: This content has been made available to all.
